OverviewChartNewsTraderScreen

BVT Discount Zert BIIB 28.03.2025/  DE000VD39R48  /

EUWAX
5/24/2024  8:54:19 AM Chg.-1.34 Bid9:59:45 PM Ask9:59:45 PM Underlying Strike price Expiration date Option type
167.09EUR -0.80% -
Bid Size: -		 -
Ask Size: -		 Biogen Inc - USD 3/28/2025 Call
GlobeNewswire 2:35 PM BIIB INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Biogen, Inc. Investors with ...
GlobeNewswire 3:00 AM BIOGEN ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Again...
GlobeNewswire 2:18 AM Stockholder Alert: Robbins LLP Informs Investors that a Shareholder Has Filed a Class Action Against...
GlobeNewswire 5/24 BIOGEN INC. (NASDAQ: BIIB) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class ...
GlobeNewswire 5/24 BIIB INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Biogen Inc. Investors with Sub...
GlobeNewswire 5/23 SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Biogen Inc. with Losses to Con...
GlobeNewswire 5/23 Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against Biogen, Inc. (BIIB...
GlobeNewswire 5/23 BIIB INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Biogen, Inc. Investors with Sub...
GlobeNewswire 5/22 Biogen Bolsters Late-Stage Pipeline, Expands Immunology Portfolio with Agreement to Acquire Human Im...
GlobeNewswire 5/21 Avadel Pharmaceuticals Appoints Naseem Amin, M.D. to its Board of Directors
GlobeNewswire 5/16 Fortrea Appoints Machelle Sanders to Board of Directors
GlobeNewswire 5/16 Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lat...
GlobeNewswire 5/15 Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Su...
GlobeNewswire 5/9 US Neurologists Report Route of Administration as a Critical Factor when Evaluating Future Parkinson...
GlobeNewswire 5/9 Royalty Pharma Reports First Quarter 2024 Results
GlobeNewswire 5/8 IMUNON Appoints Director Dr. Stacy R. Lindborg as President and CEO
GlobeNewswire 5/8 C4 Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
GlobeNewswire 5/7 Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
GlobeNewswire 5/2 Biogen Reports Progress on Corporate Responsibility Priorities
GlobeNewswire 4/29 Muscular Dystrophy Association Launches ALS Awareness Month with Public Service Announcement ‘Answer...
GlobeNewswire 4/25 Biogen Receives Positive CHMP Opinion for TOFIDENCE™ (tocilizumab), a Biosimilar Referencing ROACTEM...
TeleTrader 4/24 US closes mixed with earnings in limelight
TeleTrader 4/24 Biogen posts Q1 revenue of $2.3 billion
TeleTrader 4/24 US mostly up premarket with earnings in focus
GlobeNewswire 4/23 Recludix Pharma Announces the Appointment of Dr. Ajay Nirula, Accomplished Pharma Executive and Immu...